Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report

Statins are the most widely used cholesterol-lowering drugs for cardiovascular diseases prevention. However, some patients are refractory to treatment, whereas others experience statin-related adverse events (SRAE). It has been increasingly important to identify pharmacogenetic biomarkers for predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagli-Hernandez, Carolina, de Freitas, Renata Caroline Costa, Marçal, Elisangela da Silva Rodrigues, Gonçalves, Rodrigo Marques, Faludi, Andre Arpad, Borges, Jéssica Bassani, Bastos, Gisele Medeiros, Los, Bruna, Mori, Augusto Akira, Bortolin, Raul Hernandes, Ferreira, Glaucio Monteiro, de Oliveira, Victor Fernandes, Hirata, Thiago Dominguez Crespo, Hirata, Mario Hiroyuki, Hirata, Rosario Dominguez Crespo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859822/
https://www.ncbi.nlm.nih.gov/pubmed/33553369
http://dx.doi.org/10.21037/atm-20-5540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859822/
https://www.ncbi.nlm.nih.gov/pubmed/33553369
http://dx.doi.org/10.21037/atm-20-5540

Ejemplares similares